SAN DIEGO--(BUSINESS WIRE)--Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., is hosting a reception for Israeli companies in conjunction with the 2014 BIO Convention. This satellite event will feature remarks from Avi Hasson, Chief Scientist of the Ministry of Economy of Israel, and a panel discussion on sourcing life science innovation and investments. The reception will take place at Mintz Levin’s San Diego office on Monday, June 23.
Jeremy D. Glaser, co-chair of Mintz Levin’s Venture Capital & Emerging Companies Practice, will deliver opening remarks followed by a panel discussion entitled, “Sourcing Life Science Innovation & Investment Opportunities from Abroad: Criteria, Challenges, and Opportunities Relevant to Early-Stage Life Science Start-Ups.” Mr. Hasson will give a closing address.
Mintz Levin has served as one of the leading law firms to the life sciences industry since the industry’s birth in the 1970s. Today, we advise hundreds of businesses and other organizations in all sectors of the industry’s ecosystem -- from start-ups looking for their first funding to public companies with products on the market, as well as venture capital firms, investment banks, and research and academic institutions. Our attorneys provide experienced counsel to clients globally in a broad range of matters, including corporate finance and securities, mergers and acquisitions, licensing and collaborations, intellectual property, litigation, regulatory, antitrust, employment and benefits, bankruptcy and commercial lending, immigration, and real estate. Mintz Levin is a full-service law firm comprised of 470 attorneys with eight offices (Boston, New York, San Diego, San Francisco, Washington, Stamford, Los Angeles, and London) and an affiliate relationship in Israel.
For more information about Mintz Levin, please visit www.mintz.com.